CSMBMEET2023

Dr. Blagg received a B.A. in Chemistry and Environmental Studies from Sonoma State University in 1994. He then went on to earn a Ph.D. in organic chemistry from the University of Utah in the laboratory of Dale Poulter. Following the completion of his Ph.D., he was a NIH postdoctoral fellow at the Scripps Research Institute, wherein he studied in Dale Boger's laboratory until 2002. Dr. Blagg began his independent research career as a medicinal chemistry professor at The University of Kansas, where he remained until 2017. In 2017, Dr. Blagg became the director of the Warren Family Research Center for Drug Discovery and Development at the University of Notre Dame and the Charles Huisking Professor of Chemistry and Biochemistry. His research focuses on the design, synthesis, and evaluation of HSP90 inhibitors.

Richard Denk has studied mechanical engineering and did examination on Experts of GMP, Qualification and Validation, Pharmaceutical Auditing, Pharmaceutical Engineering, Quality Control on the University of Applied Sciences in Albstadt/Sigmaringen Germany. Richard Denk is working at the company SKAN AG, headquartered in Allschwil CH in the position Head Containment. Mr. Denk founded 10 years ago the expert Containment group CoP of the ISPE D / A / CH. The ISPE CoP Containment published the ISPE Containment Manual in September 2015. The ISPE Containment Manual does provide a full overview on Containment. Furthermore, Mr. Denk is author at Maas & Peither GMP Publishing on containment and hygienic design and one of the authors of the ISPE Oral Solid Dosage Baseline Guide Volume 2 and Volume 3. Mr. Denk has spent more than 20 years with the subject production of highly active / highly hazardous substances and has developed the containment pyramid.

Raffaele Pilla, Pharm.D., Ph.D., Doctor Europaeus, received his Master’s degree in Pharmacy at G. d’Annunzio University in Chieti-Pescara, Italy in 2005, where he also served internships at the Cell Physiology Laboratory and Molecular Biology Laboratory. Prior, he was an Erasmus Student at Faculté de Pharmacie de Reims in Reims, France. He received his Doctor Europaeus in 2010 from Pitié-Salpétrière Institute in Paris, France. Also in 2010, he received his Ph.D. in Biochemistry, Physiology, and Pathology of Muscle at G. d’Annunzio University in Chieti-Pescara, Italy. He was hired as a Postdoctoral Scholar in the Department of Pharmacology and Physiology at the University of South Florida in Tampa, on two research grants funded by the Office of Naval Research (US Navy) and Divers’ Alert Network. He has written and lectured widely worldwide. He has been involved in ongoing research at the University of South Florida with the use of ketone esters.

Dr Carlos Orozco is a scientist, author, speaker and lecturer whose diverse scientific career includes professional training in Biochemistry, Immunology, Biophysics, Epigenetics, Reproductive Medicine, Reproductive Biology, Orthomolecular Medicine, Traditional Chinese Medicine, Integrative Medicine, Quantum Physics, and Quantum Biology. An Australian University offered Dr Carlos a PhD scholarship to move from Mexico. He has since gone on to author the book ‘Key to Coherence’ and is the inventor of a method and product which creates a quantum morphic energy field all of which he calls the ‘Symphony of Love.’ He holds a Bachelor of Science Degree in Experimental Biology, majoring in Biochemistry and Biophysics, a Masters Degree in Immunology, and a PhD in Biochemistry, with a further 5 years as a Postdoctoral Fellow. He specialised in Reproductive Medicine, and Reproductive Biology, Gynaecological Oncology, Clinical Nutrition, and Traditional Chinese Medicine. He is the International Vice President of the ‘World Association for Excellence in Health’ (AMES Mundial), he operates from Australia and joined our advisory board in 1-2022.

Prof. Sinerik Ayrapetyan has received his PhD in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev during the period of 1966-1970. Currently, he is the coordinator of UNESCO Chair at Life Sciences International Postgraduate Educational Center, Yerevan, Armenia. His research has included the study of metabolic regulation of cell function in norm and pathology. He is serving as a Chief Editor for the Journal of “Bioequivalence and Bioavailability”, and an editorial member of several reputed journals like “Electromagnetic Biology and Medicine”, “ISRN Biophysics”, “European Journal of Biophysics”, “Advances in Life Sciences", “Applied Pharmacy”, “BBA General Subjects”, “International Dental and Medical Research", “International Journal of Basic and Applied Sciences”, “Insights of Medical Sciences”, “Chronicles of Pharmaceutical Science Journal”, “Clinical Investigations”, “Global Drugs and Therapeutics” etc. Prof. Sinerik Ayrapetyan is a member of a number of international societies, such as International Society of Invertebrate Neurobiology (ISIN), International Society for neurochemistry (ISN), European Society for Neurochemistry (ESN), International Brain Research Organization (IBRO), International Union of Pure and Applied Biophysics (IUPAB), Bioelectromagnetics Society (BEMS), WHO International Advisory Committee on Electromagnetobiology and the president of “All Armenian Research Council”. He has authored 7 international books and 115 research articles.

Dr. AC Martin is a professor of Microbiology and Immunology from Stanford University School of Medicine. He was born in USA and completed his PhD in the year 1969 in the field of microbiology from University of California, Los Angeles. Professor Martin is having a teaching knowledge of around 55 years. He is an active member for many microbiological and immunological societies and association. Professor Martin received the Fulbright Scholar award in the year 1964-1971. He is the author for 142 publications along with few patents. He has been a part of many scientific conferences during his teaching and educational career. He had received the funding from reputed organization for his research work. His current research interest includes immunology, Microbiology, Cancer, Genetics studies etc. Currently Professor Martin is working on Exosome (EV) project and also on the Extension of the ongoing antibiotic work.

Thomas J. Webster’s (H index: 116; Google Scholar) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has served as a professor at Purdue (2000-2005), Brown (2005-2012), and Northeastern (2012-2021; serving as Chemical Engineering Department Chair from 2012 - 2019) Universities and has formed over a dozen companies who have numerous FDA approved medical products currently improving human health. He is currently helping those companies and serves as a professor at Hebei University of Technology, Saveetha University, Vellore Institute of Technology, UFPI, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies.Prof. Webster is a former President of the U.S. Society For Biomaterials and has over 1,350 publications to his credit with over 53,000 citations. He was recently nominated for the Nobel Prize in Chemistry (2023).

Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company Wright-Wold Scientific, the pharmaceutical company CTE cure, and was a science advocate on Capitol Hill through the Washington Fellow’s program.

Recognised as a world leading Expert in consumer Corona Cold Air Plasma Medicine medical devices using Quantum Physics for therapeutic benefits across the biological systems of the human body and blood. For ongoing live research without excluding any patients she has commenced a decentralised hybrid clinical case study unit for all willing participants. Recently advancing the original technology she patented the world’s first “systemic selective adaptogen” using non-equilibrium atmospheric air to work alongside pharmaceuticals and vaccines without interference or alone. “It’s a physics solution to human health for any age, not a chemical solution.” Her patient results have inspired scientists around the world, today she is in demand speaking internationally since her return from Wuhan 3-2020, including to the United Nations science committee in 2021. She has 10 years’ experience across 38 multidisciplinary scientific and medical fields as an Independent Scientist; following 16 years of academic training with an impressive 30 year career as an International Chief Executive across 17 countries; including 9.5 years in Fortune 50 companies and International diplomacy. She’s a ‘humanitarian, on a mission to improve global health systemically.’

Michael B. Fossel, M.D., Ph.D. (born 1950, Greenwich, Connecticut) is a former professor of clinical medicine at Michigan State University and is the author of several books on aging, who is best known for his views on telomerase therapy as a possible treatment for cellular senescence. Fossel has appeared on many major news programs to discuss aging and has appeared regularly on National Public Radio (NPR). He is also a respected lecturer, author, and the founder and former editor-in-chief of the Journal of Anti-Aging Medicine (now known as Rejuvenation Research).[citation needed] Prior to earning his M.D. at Stanford Medical School, Fossel earned a joint B.A. (cum laude) and M.A. in psychology at Wesleyan University and a Ph.D. in neurobiology at Stanford University. He is also a graduate of Phillips Exeter Academy. Prior to graduating from medical school in 1981, he was awarded a National Science Foundation fellowship and taught at Stanford University.[citation needed] In addition to his position at Michigan State University, Fossel has lectured at the National Institute for Health, the Smithsonian Institution, and at various other universities and institutes in various parts of the world. Fossel served on the board of directors for the American Aging Association and was their executive director

Alain Chapel For 25 years, he has been developing gene and cell therapy using non-human primates, immune-tolerant mice and rats to protect against the side effects of radiation. He collaborates with clinicians to develop strategies for treatment of patients after radiotherapy overexposures. He has participated in the first establishment of proof of concept of the therapeutic efficacy of Mesenchymal stem cells (MSCs) for the treatment of hematopoietic deficit, radiodermatitis and over dosages of radiotherapy. He has contributed to the first reported correction of deficient hematopoiesis in patients (graft failure and aplastic anemia) thanks to intravenous injection of MSCs restoring the bone marrow microenvironment, mandatory to sustain hematopoiesis after total body irradiation. He is scientific investigator of Clinical phase II trial evaluating the efficacy of systemic MSC injections for the treatment of severe and chronic radiotherapy-induced abdomino-pelvic complications refractory to standard therapy

Dr. S.Y. Seong, M.D., Ph.D. in Microbiology and Immunology, now is a Professor and Ex Director of Wide River Institute of Immunology, Seoul National University College of Medicine. He got Ph.D. in Microbiology and Immunology in Seoul National University College of Medicine in 1995. He got Hamchun Medical Award, award of International Conference on Inante Immunity in Greece, the best poster award of DC 2007 in Germany in 2007, Yuhan Medical Award, Seoul Medical Association in 2012 etc. He is also the member of Korean Society for Microbiology, Korean Society for Immunology, American Society for Microbiology, and American Society for Immunology. He was a president of Korean Society for Dendritic cells and secretary of International DAMPs association. He suggested DAMPs model for the first time on Nature Rev. Immunology in 2004, which brought novel insight of modern innate immunology. He is now working on development of new therapeutics for COVID-19, atopic dermatitis and Alzheimer disease based on DAMPs model. He found that GPCR19 agonists could ameliorate inflammation not only in preclinical models but also in phase 2 clinical trials. He has also worked on development of nanobodies in immuno-oncology fields.

Professor Yoram Baram of the Computer Science department at the Technion received the BSc degree in Aeronautical Engineering from the Technion in 1972, the MSc degree in Aeronautics and Astronautics from MIT in 1974, and the PhD degree in Electrical Engineering and Computer Science from MIT in 1976. Specializing in control theory, he spent the next twenty years investigating and teaching system dynamics in Israel and in the US, including two sabbatical terms as a Senior Research Associate of the National Research Council at the NASA Ames Research Centre, where he also served as a consultant in 1986–2006. In 1999–2004 he developed a virtual reality apparatus for gait improvement in neurological patients, for which he was awarded a US patent. In 2005 he received the Research Award for Best Platform Presentation in the conference on multiple sclerosis CMSC. In 2006 he was appointed the incumbent of the Technion’s Roy Mattas/Winnipeg Chair in Biomedical Engineering. The effectiveness of the sensory feedback device in the improvement of gait in adults and in children with neurological disorders was clinically tested and published in leading medical journals during 2002–2016. Professor Baram has supervised about thirty graduate students. In recent years he has been working on a mathematical theory of dynamics and information coding in neurobiological systems, and serving as head of the Technion Centre for Research in Intelligent Systems. Having retired in 2015, he maintains a full research schedule at the Technion, publishing his work in leading neuroscience journals.

Professor Stefan Glück, MD, PhD, FRCPC is V.P of Global Medical Affairs, at Celgene Corporation since October 2014, and a medical oncologist with focus on breast cancer. He has overseen breast, ovarian, pancreatic and bladder cancer activities worldwide, as well as the Immuno-Oncology Program in solid tumors. Recently, his job requirements have shifted to include all solid tumors and most importantly Early Assets. He previously served as a Sylvester Professor in the Department of Medicine at Miller School of Medicine, University of Miami, Florida until September 2014. From 2003–2008, he was the Clinical Director of the Braman Family Breast Cancer Institute, and from January 2009 - December 2010 Assistant Director of the Sylvester Comprehensive Cancer Center and Associate Chief, Division Hematology & Medical Oncology. He has been a PI of 37 clinical studies of breast cancer in Miami, as well as investigator in numerous scientific, translational projects. He has authored or co-authored over 270 articles. In addition, Dr Glück has written or co-written several book chapters and numerous journal abstracts, and has presented more than 380 papers at national and international meetings.

Dolashka’s group has wide experience in the isolation, purification, and characterization of biologically active compounds. She has more than 130 publications on these topics, 3 book chapters and 7 patents. Prof. Dolashka is Editor-in-board of 3 journals and representative IUPAC. She is coordinating several international research projects, sponsored by NATO (Brussels), the European Commission, Germany (DFG and BMBF), CNR (Italy), FWO (Belgium), China, and Ukraine. She also participates in BG05M2OP001-1.002-0019: "Clean Technologies for Sustainable Environment - Water, Waste, Energy for Circular Economy". Total value: 23667925.86 lv (20117736.97 European and 355018.89 lv national co-financing).

Peter A. Hancock, D.Sc., Ph.D. is Provost Distinguished Research Professor in the Department of Psychology and the Institute for Simulation and Training, at the University of Central Florida (UCF). At UCF in 2009 he was also created the 16th ever University Pegasus Professor (the Institution’s highest honorand in 2012 was named 6th ever University Trustee Chair. He directs the MIT2 Research Laboratories and Associate Director of the Center for Applied Human Factors in Aviation (CAHFA). He is also an affiliated Scientist of the Humans and Automation Laboratory at MIT, a Research Associate of the University of Michigan Transport Research Institute, and a Senior Research Associate at the Institute for Human and Machine Cognition in Pensacola, Florida

Sergey Suchkov was born in the City of Astrakhan, Russia, in a dynasty of medical doctors, graduated from Astrakhan State Medical University and was awarded with MD. Then maintained his PhD and Doctor’s Degree. And later was working for Helmholtz Eye Research Institute and Moscow Regional Clinical Research Institute (MONIKI). Dr Suchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is: (i) Scientific Director of the Institute of Global Health. (ii) Chair of Dept. for Personalized Medicine and Precision Nutricology of MGUPP. (iii) Professor, Dept. for Clinical Immunology, A.I. Evdokimov MGMSU, Russia. (iv) A Member, New York Academy of Sciences, USA.

Andrey Sorokin graduated from the St. Petersburg State University and received his Ph.D. from the Institute of Cytology Academy of Sciences of Russia in 1981. A. Sorokin is a Head of the Laboratory at the Medical College of Wisconsin, where he is holding the position of Full Professor of Medicine with secondary appointments at Department of Physiology and Department of Microbiology & Immunology. He has published more than 100 papers in reputed journals and is serving as an editorial board member of a number of journals including Frontiers in Renal and Epithelial Physiology.

Dr. Kalliopi Megari is an experienced psychologist working in the hospital & health care industry. She is a lecturer at University of Western Macedonia in Greece. Skilled in Clinical Neuropsychology, Clinical Research and Learning Disabilities. Graduated from Aristotle University of Thessaloniki and attended further education from University of Macedonia, in people with special needs and disabilities. She holds undergraduate degrees in Nursing and Psychology, as well as a Master’s and a PhD in Neuropsychology from Aristotle University of Thessaloniki. She has many years of experience working with chronic disease patients as well with people with disabilities. Her work has earned her many prestigious international awards. She has given lectures at Aristotle University of Thessaloniki and University of Warsaw. She is postdoctoral researcher and has published more than 10 research articles in journals. She is the Global Engagement Representative of International Neuropsychological Society, General Secretary of the booard of directors and member of the Ethics Committee of Hellenic Neuropsychological Society.

Inga Urlić, PhD, works as a professor associate at the Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb. Her research field is biomedicine with a focus on tumor biology, stem cell biology and tissue engineering - bone and cartilage regeneration. She is the principal investigator of 3 competitive research projects (MZOS, BICRO, HRZZ), 2 research donations (HAZU, HEP), 1 R&D project and the group leader within 1 Horizon2020 project. She is a co-author of 42 scientific papers, 53 abstracts and invited speaker at three international conferences. She is lecturing five courses - Mutagenesis and Carcinogenesis, Research Methods in Molecular Biology, Stem Cell Biology, Introduction to Forensic Biology and Workshops in Cell and Molecular Genetics. She mentored more than 20 graduate students and 8 doctoral theses. She is active as a project evaluator and reviewer for scientific journals and member of several professional associations – Tissue engineering and regenerative medicine society, European association for cancer research, International society for applied biological sciences and Croatian biological society.

Associate Professor, Dr. AleksandarDolashki works at laboratory "Chemistry and Biophysics of proteins and enzymes" in Institute of Organic Chemistry with Centre of at the Bulgarian Academy of Sciences. His scientific interests include the isolation, characterization and application of bioactive substances from natural sources, mainly proteins, glycoproteins and antimicrobial as well as studying their mechanism of action. In the studies, she uses different chromatographic and spectral methods, mass spectrometry, proteomic analysis and bioinformatics. Assoc. Prof. Dr. AleksandarDolashki participates in many national and international research projects and he is co-author of over 60 papers.

Dr. Yan Leyfman, MD, has been recognized as one of the top international researchers in oncology by ASH and ASCO. During the COVID-19 pandemic, he was recruited as the Director of the Immunology Division of the Global COVID-19 Taskforce, which produced one of the first mechanisms for SARS-CoV-2 and COVI-Flu along with therapeutic interventions for both. In 2021, Dr. Leyfman presented the first mechanism to explain the interplay between cancer and COVID-19 at the 2021 ASCO Annual Meeting. His work has been published as the cover article in the journal, Shock, and in the textbook, Insights on a Post-COVID World.

RM was born in Sofia, Bulgaria in 1930. His father was a physician and head of the Jewish hospital in Sofia. RM went to an American Grade School in Sofia for 4 years until it was closed by the pro-German government. From 1942, for over 2 years –during the 2nd world war - his family lived in small villages in the Balkans. His parents believed that the family is safer there. Nevertheless his father was taken to a concentration camp for part of this time. RM immigrated to Israel in 1949. He studied biochemistry at the Hebrew University in Jerusalem (M.Sc.)and the Weizmann Institute in Rehovot (Ph.D.) He spent a year in New York, at the Rockefeller Institute and returned to the Weizmann Institute in 1960. He worked on the chemistry of various natural products. He initiated his work on hashish, which he received from the Police. In 1966 he moved to the Hebrew University, where he became a full professor in 1972. From 1979 to 1982 he was Rector (Academic Head) of the Hebrew University. He retired in 2000 but continued his research. He still has a lab with 3-4 post-doctoral researchers. His work has been mostly on the chemistry of natural products, the best known being on cannabinoids. In collaboration with numerous colleagues in Israel and abroad he has also published in pharmacology and on clinical trials. He has published about 470 scientific papers and has received numerous national and international prizes, including the Israel Prize – the most prestigious Israeli Prize – as well as a prize from the US National Institutes of Health. He is a member of the Israel Academy of Sciences, where he headed the Natural Sciences section from 2007 to 2013. He married Dalia (born Borovitch) in 1955 and they have 3 children, Roy, a professor of mathematics at the Technion in Haifa, Hadas, an M.D. ophtalmologist and Dafna, an M.D. pediatric neurologist. He has 7 grandchildren.

Diane P. Banks is an Assistant Professor in Biological Sciences at Bronx Community College, where she also serves as Program Director for the Medical Laboratory Technician Program. In 2019, she anticipates to complete her Ph. D. in Urban Education for Math, Science and Technology at the City University of New York. Her research specializes in Microbiology with a focus in soil and water microbiome; Epidemiology with a focus in STI’s; STEM education with a focus on faculty preparation and learned helplessness; and Science History Education with a focus on rediscovering the contributions of African Americans in science education. Her book, The business of education: Networks of powers and wealth in America, was published by Taylor and Francis in 2017. Furthermore, her work has been published in Theory, Research, and Action in Urban Education. Mrs. Banks’ awards and honors include a 2017-2018 Science Teaching Fellowship with the American Society for Microbiology and National Certification as a Medical Laboratory Scientist from the American Society for Clinical Pathology in 2015. Her research has been funded by grants from the CUNY Research Scholars Program and BCC’s Student Government.

Associate Professor, Dr. Lyudmila Velkova works at laboratory "Chemistry and Biophysics of proteins and enzymes" in Institute of Organic Chemistry with Centre of at the Bulgarian Academy of Sciences. Her scientific interests include the isolation, characterization and application of bioactive substances from natural sources, mainly proteins, glycoproteins and antimicrobial as well as studying their mechanism of action. In the studies, she uses different chromatographic and spectral methods, mass spectrometry, proteomic analysis and bioinformatics. Assoc. Prof. Dr. L. Velkova participates in many national and international research projects and she is co-author of over 60 papers.

Irina V Guzhova graduated in St.Petersburg State University and received her PhD (1989) and Dr.Sci (2005) from the Institute of Cytology of Russian Academy of Sciences. The interests of the Guzhova’s lab lie in the field of the cell proteostasis systems. When applied to tumor cells, overactivated proteostasis leads to failure of antitumor therapy, to higher tumor aggressiveness as well as to tumor recurrence. Now Irina Guzhova is a Head of the Cell and Molecular Interaction Department, and vice-director of the Institute of Cytology of Russian Academy of Sciences. She is an author of more than 150 research publications

We'll update soon..

Dr. Chulso Moon is the founder and President of the BCD Innovations USA, biotech company located in the Johns Hopkins Medical Campus, which is dedicated for screening lung and bladder cancer. Dr. Moon is a MD PhD physician scientist and earned his Ph.D. in Human Genetics and Molecular Biology from The Johns Hopkins University School of Medicine. His doctoral work included the cloning of the human gene for AQP1, a unique water channel molecule, under the mentorship of the Nobel Laureate Dr. Peter Agre. After he finished his internal medicine and oncology training in MD Anderson Cancer Center, he had served as an attending physician in Johns Hopkins Cancer Center and faculty in Johns Hopkins Medical School. He also has served as a thesis advisor for the Human Genetics Program. Most recently, he has been serving as a director of oncology at the “Easton Oncology Associate” in Easton, PA. Presently, he has been board certified in internal medicine and medical oncology from American Board of Internal Medicine. Dr. Moon has devoted in the last 2 decades for the discovery of novel genes causing various hematooncologic malignancy, metabolic disease and neurodegenerative disease. These exciting discoveries have been based on the new interpretation of human genome structure and their functional organization. For example, Dr. Moon has discovered numerous new proteins originated from previously “undiscovered novel genes” and has been characterizing the role of these novel genes in various human diseases. Particularly, Dr. Moon has been developing various technologies for his early cancer detection efforts. These efforts have been based on his collaboration with Johns Hopkins, where he had served as an attending physician and faculty since 2001, Roche Diagnostics (Germany), Olympus, Fuji Film and JSR Corporation (All Japan). Since 2001, Dr. Moon has licensed a global DNA based cancer detection technology from JHU. Dr. Moon had collaborated with Roche Diagnostics to develop “bladder cancer detection kit”. From 2001 to 2010, Dr. Moon has been leading “bladder cancer detection trial, multi-institutional pivotal validation trial with his colleague, Dr. M. Sheonberg and D. Sidransky” for the purpose of US FDA Approval. Since then, due to changes in US insurance company reimbursement, Dr. Moon has formulated a new recurrent bladder cancer detection kit. Most recently, with the relationship with Affymetrix (CA, USA), he developed a more efficient technology and has been formulating another FDA trial for screening hematuria among smokers. Dr. Moon has worked with Olympus to develop a lung cancer detection test. However, the “lack of gene chip” at the time of collaboration has been a hurdle. While Olympus and SONY has launched the largest “Gene Chip Company in the World”, Dr. Moon has decided to work with Affymetrix (the best Gene Chip manufacturer in the world) and developed a “Lung Cancer Susceptibility Gene Chip”. It is expected that this kit will be available to hospital in early 2015. This kit, when combined with chest CT scan, can significantly improve “early detection of lung cancer by annual chest CT”. Therefore, it not only can save millions of lives but also is expected to significantly reduce the cost of lung cancer management incurred to insurance carriers.Due to his contribution in the field of early cancer detection, he was invited to make a speech during 2006 Science and Technology Symposium (STS, Kyoto Japan) as a world 100 best scientist, selected by Japanese Government, for the topic of cancer management and again in 2008 STS forum (Kyoto, Japan) for the topic of early lung cancer detection. Recently he has founded BCD Innovations USA (bcdinnovationsusa.com) and successfully commercialized MSA based bladder cancer screening program and also developed GMP based cancer screening kit factory in China.

Kathleen Hefferon received her Ph.D. in Molecular Virology at the University of Toronto.Dr. Heffron has worked on the faculty at the Division of Nutritional Sciences at Cornell and has written two books on biopharmaceuticals in plants. She teaches and conducts research at both the University of Toronto and Cornell University. Kathleen has 4 patents, has edited 6 books, and has multiple research publications.

I studied Medical Surgeon at the Universidad Mayor and then I graduated as an Adult Neurologist at the University of Chile, I took the Electroencephalography and Epilepsy Fellowship at the Pontificia Universidad Catolica de Chile. I currently work as a teacher at the Finis Terrae University, Neurologist in epilepsy and electroencephalography, Neurology Polyclinic and in the Stroke Treatment Unit at the San Juan de Dios Hospital. I have published papers on Epilepsy and pregnancy as well as neurological sequelae in cranial brain trauma in patients with traffic accidents.

Dr. Mauro Luisetto, obtained his Pharm D in 1995 from the Turin University and worked as European specialist in laboratory medicine. Currently, he works as Public Hospital Pharmacist Manager and is responsible of hospital medicinal gas quality control PC HOSP. He is also the Director of hospital medicinal gases contract implementation. His working filed and rotation is biochemistry, toxicology, blood bank, haematology. microbiology; hospital pharmacy (drugs logistic, galenic, medicinal gas quality controller , radio drugs, rx contrast agents, departmental pharmacist); clinical pathology, antidothes responsible stokes provincial PC, logistic of diagnostic in vitro), responsible for emergency drug hospital stokes.

Prof. Ehud Razin received his B.Sc.in Biology and M.Sc. in Microbiology from the Hebrew University and his Ph.D. in Immunology from the Weizmann Institute of Science, Rehovot, Israel. Prof. Razin has for many years been a major contributor and leading scientist in the field of mast cell biology. In 1980, while most investigators used rat peritoneal mast cells as a model for study their function, he successfully developed a cultured mouse bone marrow derived system as a mast cells model1. This system still serves as the main tool for studying mast cell function. Prof. Razin’s long term goal has been to try to ascertain the regulation of gene transcription in mast cells due to their interaction with their growth factors and in response to trigger by immunological stimulus through their surface FCεRI receptors. His team has explored the relationship between aggregation of mast cell surface receptors and AP-1, USF2 and microphthalmia transcription factor (MITF) transcriptional activity. Prof. Razin continued to push the mast cell field ahead by discovering few years ago a new signaling pathway in mast cells and other cells which directly involved in gene regulation. His team observed that in variety of cells LysRS forms a complex with either MITF or USF2, while Ap4A produced by LysRS causes the release of Hint-1 from these two transcription factors. As Hint-1 suppresses the transcriptional activity of MITF and USF2 in these cells, Ap4A could act as a general regulator of the transcriptional activity of transcription factors belonging to the HLH family of proteins2 3. His team also researches the molecular mechanisms of the inhibition of MITF and STAT3 transcriptional activity by PIAS34 5 6. Other aspects of Prof. Razin’s mast cell research include the dependence of Bcl-2 on its association with HSP90β for its anti-apoptotic function in mast cells7. Recently Prof. Razin has added an exciting new direction to his laboratory’s research by investigating MITF’s functions in the heart8. A role of MITF in cardiac hypertrophy has being demonstrated and the cardiac isoforms of MITF have been characterized.

Joseph Mancini completed his Ph.Din Biochemistry and Molecular Biology at McGill University. He began his industry career at Merck & Co where he stayed for 20 yrs and discovered a novel therapeutic for the treatment of osteoarthritis (etoricoxib). He then spent 8 years at Vertex Pharmaceuticals and was a Director in Exploratory Research in Boston, MA and led a biology program on DM1. Presently he is Vice President and Head of Biology at adMare BioInnovations in Montreal and is focused on creating novel biotech startups in the Canadian community. He has over 90 peer reviewed publications and 7 patents

Klaus Ammann is a Professor emeritus at University of Bern. Born: 6 December 1940 in Bern, Thesis: Vegetation and Glacier history, summa cum laude in 1972 Bern University. Assisting to Swiss Atlas of Plant Distribution, first Swiss research department on Lichenology (chemosystematics and bio-monitoring air pollution). Teaching in plant biodiversity and vegetation ecology, Director of the Bern Botanic Garden 1996-2006 and Prof. h.c. 2000. Sabbatical stays: Bergen, Norway, Duke University in North Carolina, University of the West Indies in Jamaica, and Missouri Botanical Garden in St. Louis. Emeritus 2006, guest prof. Delft University of Technology, Sabanci University in Istanbul and Tehran 2017. Moderating ‘Berne Debates’, early blog on plant biotechnology, presently—ASK-FORCE at PRRI (Public Research and Regulation Initiative) FORUM at European Federation of Biotechnology, KLAUSBLOG at Black Sea Biotechnology Association and since 2017 frequent contributions for literature blog of Klaus Jany. Numerous committees: Chair European expert committee on plant conservation, Council of Europe, founding member Planta Europa, Swiss Biosafety Committee: Biodiversity Section of EFB. Several Swiss and European research projects on gene flow, plant conservation, lichen chemosystematics and monitoring air pollution. Publications on biogeography, vegetation history, vegetation ecology, plant systematics (monography on Bromus), gene flow of crops and their wild relatives and agricultural biodiversity. He also has a special interest in Pythagorean Harmonics science and holistic questions in evolution.

Professor Dr. Luisa Maria Arvide Cambra, Spanish is now Professor with Chair at the University of Almería (Spain) and she was Assistant Professor and Associate Professor at the University of Granada from 1979 on. Thirty-nine years of the teaching and researching experience. She is the Director of Research Group HUM113-Estudios Filológicos from Program of Research of Andalusian Government, where she has managed and directed several academic and scientific contracts and research projects, as well as a Member of Athens Institute for Education & Research (ATINER) in Greece, The Academic Genesis Platform (UAGP) in UK&Turkey and Experts of Academic Excellence Research Centre (EAERC) in Jordan; etc. She is the author of many works on several aspects of Arabic science and literature in the Middle Ages, as well as Arabic language and linguistics. She has also participated in different prestigious international scientific Conferences. She has visited many universities and academic institutions of Europe, the United States and Arab countries in order to teach and research. Among her works, we have the study and the translation to Spanish of some treatises of Kitab al-tasrif´s Al-Zahrawi, Ibn Qutayba´s texts, Maqamas of Al-Hariri, The Sicilian Questions of Ibn Sab´in, etcetera. She has published 11 books and over 90 articles and papers in prestigious international journals and proceedings.

Stuart Maudsley has been recognized as a visionary pioneer in science (both physical and biomedical) from childhood where his work was publicized on the national television program ‘The Power Game’ – a U.K. wide engineering Olympiad. Stuart has been subsequently awarded and recognized throughout his career as both an intellectual innovator and as an excellent scientist. Stuart’s primary contribution to science is in the field of receptor systems biology and pharmacotherapeutics design – within this field Stuart is one of the world’s leading young Investigators. Stuart graduated from the University of Leeds with First Class Honors in Pharmacology and was awarded the Pfizer Prize for undergraduate research. For his doctoral work Stuart was one of only 6 recipients (from a University population of 40,000) of the Universities venerated ‘Named Scholarships’, i.e. the Ackroyd, Brotherton and Brown Scholarship. After gaining his Ph.D. in Receptor Pharmacology, he was then awarded a Howard Hughes Medical Institute Fellowship Award to train with Professor Robert Lefkowitz (2012 Nobel Laureate in Chemistry) at Duke University. Following this fellowship Stuart was instantly recruited to be Principal Investigator of the Receptor Biology Section at the Medical Research Council (MRC) -Human Reproductive Sciences Unit at the University of Edinburgh. During his time at the MRC his drug discovery and development abilities was implicit in his recruitment as a scientific advisor to Ardana Bioscience Inc. where he subsequently developed a novel prostate cancer therapeutic. To broaden his already considerable biomedical experience Stuart then accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health (NIH-National Institute on Aging) at the Johns Hopkins University Medical Center

Dr Ghanem was qualified in 1968, Mansoura University, Egypt. He gained all postgraduate experience in UK where he was promoted in posts up to the consultant level. He practiced as consultant Urologist in UK, Saudi Arabia and Egypt. During his career life he reported over 60 articles of which he made important discoveries in medicine, physiology, urology, nephrology, cardiovascular and surgery. He discovered two new types of vascular shocks, proved that one physiological law is wrong and provided an alternative. He resolved the puzzles of 3 clinical syndromes; the transurethral of the prostate (TURP) syndrome, the loin pain haematuria syndrome (LPHS) and the adult respiratory distress syndrome (ARDS). He is now the Editor-in-Chief for The Surgical Medicine Open Access Journal (SMOAJ). Now he is happily retired in Egypt.

Farid Menaa (B.Sc. Eng., B.Sc. Bio., M.Sc. Genetics, Master Gerontology/Geriatry, Ph.D. Radiation Oncology and Gerontology, EMBA Entrepreneurship and MD candidate), is an inter- and multi-disciplinary professional. He is a Professor, principal investigator, Director, consultant editor, reviewer, event organizer, and entrepreneur. He earned his degrees with highest distinctions from prestigious French universities and institutions. He followed a post-doctoral in oncology as a NIH-fellow (San Diego, California, USA; 2004-2007). Subsequently, he pursued his career in dermatology, and stem cells as a DFG-Fellow (Wuerzburg, Germany; 2007-2009). Then, he was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, he was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (São Paulo, Brazil; 2010-2012). He authored and co-authored more than 100 publications (including peer-reviewed ISI research and review articles, books, book chapters, conference proceedings, patents). He is often invited as a speaker; keynote/featured speaker and (co-) chairman to reputed world congresses and institutions, where he is offering speeches in various areas of medicine, sciences, and technology

Dr. Yodoi is a Prof.Em. of Kyoto University and is the Chairman of JBPA (Japan Biostress Research Promotion Alliance). He was a Professor of in Department of Biological Responses, Insitute for Virus Research (IVR), Kyoto University, retiring in April 2010. After graduation from Kyoto University Medical School in 1971 and upon completing postgraduate courses in the University Hospital and the IVR, he was appointed as Assistant Professor in the Institute for Immunology in the Medical School. Between 1977-1980, Dr. Yodoi was a Research Associate in Johns Hopkins University Department of Medicine under Prof. Kimishige Ishizaka. After, he returned to Kyoto Univ. and was appointed as Professor in the Department of Prevention and Therapeutics, IVR in 1989, and the moved to the Department of Biological Responses in 1990. He was also appointed as the Human Stress Signal Research Center, Head of BioMedical Special Research Unit, AIST (National Inst Advanced Industrial Science and Technology Japan) from 2001 to 2004. He was also a group leader of Translational Res Center, Thioredoxin Project in Kyoto Univ. Hospital from 2003 to 2007.

Magnus S. Magnusson, PhD, Emeritus Research Professor, founder and director of the Human Behavior Laboratory (hbl.hi.is), University of Iceland. Author of the T-pattern, T-string and T-system model and the corresponding detection algorithms and software THEMETM (PatternVision.com), initially focusing on real-time organization of behavior. Co-directed DNA analysis. Numerous papers, talks and keynotes in ethology, neuroscience, mathematics, religion, proteomics, mass spectrometry, A.I., robotics and nanoscience. Deputy Director 1983-1988 in Museum of Mankind, National Museum of Natural History, Paris. Repeatedly invited Professor at the University of Paris, V, VIII and XIII in psychology and the biology of behavior. Now works in formal collaboration between 32 European and American universities initiated 1995 at the University Rene Descartes of Paris V, Sorbonne, based on “Magnusson’s analytical model”

She is currently affiliated with the Department of Medical Imaging in University of Dundee, Scotland, United Kingdom.She completed her Bachelor of Medicine and Bachelor of Surgery from Mahatma Gandhi Institute of Medical Sciences, Deemed University, Navi Mumbai, India. She completed her one year internship from Government approved Civil Hospital, Lucknow, India. Well versed with basic diagnostic and therapeutic procedures in all the medical departments. Worked as a Radiology assistant in India, has an in depth knowledge of Human Anatomy and Physics of common Radiological Machines such as CT scan, MRI, PET scan and X rays. Has worked as a volunteer in various health camps and NGO’s to provide free medicines , perform Imaging and check ups for the patients. Her major research work was in Stereotactic Ablative Radiotherapy treatment of lung cancer patients which was approved by Caldicott as well as R&D Tayside,United Kingdom. Worked in Radiotherapy Physics Department, Ninewells Hospital ,Dundee, United Kingdom for a tenure of two months to learn about the Stereotactic Ablative Radiotherapy planning and evaluation system in the Ray Station Treatment Planning system Ver. 11B (Ray search Laboratories,U.K.).

Ventseslav Atanasov is PhD student, who works at laboratory "Chemistry and Biophysics of proteins and enzymes" in Institute of Organic Chemistry with Centre of at the Bulgarian Academy of Sciences. His scientific interests include the isolation, characterization and application of bioactive substances from natural sources, mainly proteins, glycoproteins and antimicrobial peptides, as well as studying their mechanism of action through proteomic analysis.

Fernando Cardona holds a PhD in Molecular Biology from the University of Valencia. He has published 16 articles indexed in JCR and 9 indexed in Scopus, as well as a textbook and other teaching materials. He has participated in more than 30 international congresses. In addition, he has an intense editorial activity, having reviewed more than 130 articles indexed in JCR journals and acting as an editor for 34. He conducts his research activity at the Molecular Genetics Unit of the Institute of Biomedicine of Valencia (CSIC) and teaches at the Department of Biotechnology of the Polytechnic University of Valencia.

Huang Wei Ling has completed her Graduation in Medicine in Londrina State University. She is Specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. She was the In-charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, responsible for the control of all prescribed antimicrobial medication

Professor Jenny Gunton heads the Centre for Diabetes, Obesity and Endocrinology Research (CDOER) and Westmead Institute for Medical Research (WIMR). She is Chair of Medicine at Westmead Hospital and a clinical endocrinologist / diabetologist. She received her PhD from the University of Sydney in 2003 having studied in Rob Baxter’s lab at the Kolling Institute. She completed her post-doctoral fellowship in Ron Kahn’s lab at the Joslin Diabetes Center and Harvard Medical School in 2005. She returned to Australia to the Garvan Institute and set up the Diabetes and Transcription Factors lab. In 2012 she became the President of the Australian Diabetes Society and in 2014 became Chair of Medicine at Sydney University, Westmead Hospital. Her lab moved to the new WIMR in late 2014. Her research interests include diabetes, obesity, and vitamin D. She is particularly interested in the intersection of transcription factors and their regulation by nutrients.

Dr. Omid Akbarzadeh Pivehzhani is working with Nanotechnology and Catalysis Research Centre since 2016. His main research area is heterogeneous catalysis and catalytic reaction engineering. He has spent 10 years in academic-industrial projects as a research officer and post-doctoral. Dr. Omid has worked 5 years in the oil and gas industry as a chemical engineer. He developed advanced smart catalysts, especially for the oil and gas industries. Dr. Omid has contributed to two PETRONAS Research Sdn Bhd industrial catalyst projects and worked on an international Airbus R&D project in NANOCAT. Currently, he is the PI of the graphene catalyst project at Hokkaido University in Japan, project member of FRGS grant in UTP and assigned to the NANOCAT center project. Dr. Omid was the Chairman, keynote speaker and organizing committee of many international conferences. He is currently the supervisor of three Ph.D. students from different countries. He has published many ISI papers; book chapters and has two approved and granted patents. Also, he has hands-on experience and passed several pieces of training on handling different types of equipment which are being widely used for material synthesis, characterization and performance evaluation. He is in close collaboration with other departments, government agencies and universities around the world. He is visiting researcher of Jiangsu University China and Hokkaido University Japan. He is a member of the society of petroleum engineers (SPE) and Senior Member of Hong Kong Chemical, Biological & Environmental Engineering Society. Omid awarded a full fellowship from UTP during Ph.D. and were involved for lab demonstrator and teaching in the different courses of chemical engineering. He awarded Silver Medal in 27th International Invention & Innovation Exhibition (ITEX 2016), Kuala Lumpur Convention Center in Malaysia and Silver Medal of Post Graduate Research Project in the 35th Science & Engineering Design Exhibition

Dr Tabinda Hasan is MBBS, MD, PGDHE(higher education) and PhD( Anatomy), is Assistant Professor in College of medicine, Riyadh, Saudi Arabia. She has 12 years teaching experience in anatomy and is proficient in Cadaveric Dissection and prosection, Video based case construction in Problem based learning, Research methodology, Research Ethics, Induced pleuripotent stem cell culturing techniques and Atomic force microscopy. She was awarded by Boston university school of medicine, USA(advancing ethical research award), Marie curie research award in anatomy for 2015 (with 5000 participants from over 80 countries), Stem cell unit, King Saud University ,KSA(Effective scientific vocalizations); OSDOW 2011 nominee, Elsevier, Trieste-Italy(women in science for developing world), Faculty of medicine &Health sciences, Saudi Arabia(excellence in Teaching award). She has headed the scientific committee for 3 consecutive years for Medical Research Day international conference , Saudi Arabia. She is a renowned author, with 38 Journal publications and 95 citations, 36 conference presentations including Masseuchets -USA, California, Germany, Venice-Italy, Bulgaria, Malaysia, Korea, Greece, Dubai, Abu-Dhabi, Qatar, India ,Saudi Arabia, Pakistan. She is a keen researcher and has served as principal investigator in several multinational research projects.

Dr. Yoshikazu Nakamura has served as RIBOMIC's President and CEO since 2012 when he retired from The University of Tokyo (currently Professor Emeritus). He founded the Company in 2003 when he was the UTokyo Professor at Institute of Medical Science. He has served the scientific community as the Vice President of A-IMBN since 2003, and the President of the RNA Society of Japan during 2006-2010. Throughout his academic career, Dr. Nakamura has been engaged in RNA science, and discovered a novel biological concept “molecular mimicry between protein and RNA” in 2000, which provided the basis of RIBOMIC’s R&D for aptamer therapeutics.

Human Performance, Human Movement Anatomy, PhD in Neuroscience, Research Psychology,nanotechnology ,Traumatology&Orthopedic, Project Manager , Strength and Conditioning specialist Physical Therapy,Skynesiology and Spinology, Exercise Physiology,Spa Therapist Physiology,Support Health Worker, aesthetic medical, sports masseur, expert in postural gymnastics, psychology and psychomotor for the elderly and special children or with learning disabilities. Coach and athletic trainer of various sports (football, swimming, volleyball, basketball, hockey, tennis, swimming). Spa&Clinical Manager, Lecturer in neurorehabilitation kinesiology, nanotechnology, a specialist in aesthetic gymnastics, weight-loss, and pre and postnatal, Osteopathy, Psicomotricist, aesthetic and lymphatic drainage. The lines of research on which I worked at the Department of Biotechnology and Biomedical Sciences, section of applied physiology and kinesiology and motion control, have been in the field of neuroscience, in particular in the role of beta-amyloid and glycoprotein F3 in the synaptic plasticity of hippocampal memory of mice and then in Alzheimer's disease; I dealt with behavior and various behavioral tests in mice; of electrophysiology of in vitro slices of hippocampus, stereotaxy and cannulation implantation, administration of drugs and animal welfare. In addition, I have helped other laboratories in the analysis of human movement, in neuropharmacology, in motor learning and control, in the performance of elite athletes in training programming, in rehabilitation, in the measurement of lactate in the physiology physical exercise

Dr. Harlokesh Narayan Yadav is working as Additional Professor in Department of Pharmacology, AIIMS, New Delhi. His area of interest is cardiovascular pharmacology. Having more than 14 years of academic and research experience and guided more than 45 M.Sc/M.Pharm/MD/PhD students. He has published more than 45 research papers in different national and international journals. He is the member of National Academy of Medical Sciences India (NAMS) and National Academy of Sciences India (NASI) and served as a Secretary International of Indian Pharmacological Society (IPS).Currently, he is serving as President for the Society of Pharmaceutical Education & Research (SPER) Delhi branch. As a principal investigator, he is involved in different research projects funded by different agencies i.e. AIIMS, ICMR, DBT and DST. In addition, he is awarded with the Pharmacy Ratna Award UP 2021, Dr. Manjeet Singh Award, N.N. Datta Prize, best Research Paper Award (2018) in pharmacology by Indian Journal of Pharmaceutical Education and Research and distinguished scientist award of the Society for Bioinformatics and Biological Science, Allahabad (2019).

Dimitar Kaynarov is young researcher, PhD student, who works at laboratory "Chemistry and Biophysics of proteins and enzymes" in Institute of Organic Chemistry with Centre of at the Bulgarian Academy of Sciences. His scientific interests include the isolation, characterization and application of bioactive substances from natural sources, mainly proteins, glycoproteins and antimicrobial peptides, as well as studying their mechanism of action through proteomic analysis.